SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-10
👔
Cue Biopharma, Inc.
@CUE_InsiderForm 4 Filing: Camardo Daniel A. Acquires (Grant) shares of $CUE
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Cue Biopharma, Inc.
Ticker: $CUE
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-09
Shares: 21,800
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Camardo Daniel A., holds the title of Director at Cue Biopharma, Inc..
On 2026-07-09, the insider transacted 21,800 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Camardo Daniel A. (Director) was granted $0 of $CUE
Post-Transaction Position: 21,800 shares
SEC Accession No: 0001820365-26-000009 (CIK: 1820365)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.